Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06557044 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty:

Name: The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty: — clinical trial record (NCT06557044)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PENG

StatusUnknown

PhaseNot applicable

SponsorDiakonie-Klinikum Stuttgart

Started2024-03-07

View on ClinicalTrials.gov ↗

Record status

This record was last updated August 16, 2024 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06

Trial status changed: Recruiting → Unknown

Diakonie-Klinikum Stuttgart

2 trials monitored

See all monitored trials

The aim of this study is to investigate the analgesic efficacy of the pericapsular nerve group (PENG) block during the implantation of hip endoprostheses. The study is designed as a prospective randomized double-blind study and the study participants were randomized into 2 arms and either 20 ml ropivacaine 0.5% (verum group) or 20 ml physiological saline solution (placebo group) will be applied.

Trial Details

NCT Number	NCT06557044
Lead Sponsor	Diakonie-Klinikum Stuttgart Collaborators: University Hospital Tuebingen
Conditions	Prospective, Randomized, Double-blind
Enrollment	110 participants
Start Date	2024-03-07
Primary Completion	2025-03 (estimated)
Study Completion	2025-03 (estimated)
Updated on ClinicalTrials.gov	2024-08-16